Androgen Receptor-Positive Mucoepidermoid Carcinoma: Case Report and Literature Review

被引:5
作者
Ishibashi, Kenichiro [1 ,2 ]
Ito, Yohei [1 ,2 ]
Fujii, Kana [1 ]
Masaki, Ayako [1 ]
Beppu, Shintaro [1 ]
Kawakita, Daisuke [1 ]
Ijichi, Kei [1 ]
Shimozato, Kazuo [2 ]
Inagaki, Hiroshi [1 ]
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan
[2] Aichi Gakuin Univ, Sch Dent, Nagoya, Aichi 464, Japan
关键词
mucoepidermoid carcinoma; androgen receptor; GCDFP-15; HER2; salivary duct carcinoma; SALIVARY DUCT CARCINOMA; CLINICOPATHOLOGICAL SIGNIFICANCE; FUSION TRANSCRIPT; EXPRESSION; SUBSET;
D O I
10.1177/1066896914565024
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Androgen receptor (AR) is usually expressed in salivary duct carcinoma (SDC), but only infrequently in other carcinoma types including mucoepidermoid carcinoma (MEC). The clinicopathological characteristics of AR-positive MEC remain to be clarified. Here we report a case of AR-positive MEC. A 76-year-old man presented with a growing painless tumor of the right parotid. The resected tumor was a high-grade tumor with necroses. Since the tumor was positive for AR, GCDFP-15, and HER2, SDC was first suspected, but it was also positive for CK5/6 and P63, and negative for S-100 protein and -smooth muscle actin. In addition, scattered mucous secreting tumor cells were found in the tumor nests, and they were positive for Alcian blue. A diagnosis of AR-positive MEC was finally made. The patient died of the tumor 5 years after the surgery. The present case may expand the histopathological spectrum of high-grade MEC.
引用
收藏
页码:243 / 247
页数:5
相关论文
共 18 条
  • [1] [Anonymous], 2005, PATHOLOGY GENETICS H
  • [2] BERCHEM GJ, 1995, CANCER RES, V55, P735
  • [3] An Immunohistochemical Panel for Reliable Differentiation of Salivary Duct Carcinoma and Mucoepidermoid Carcinoma
    Butler R.T.
    Spector M.E.
    Thomas D.
    McDaniel A.S.
    McHugh J.B.
    [J]. Head and Neck Pathology, 2014, 8 (2) : 133 - 140
  • [4] Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours
    Cros, J.
    Sbidian, E.
    Hans, S.
    Roussel, H.
    Scotte, F.
    Tartour, E.
    Brasnu, D.
    Laurent-Puig, P.
    Bruneval, P.
    Blons, H.
    Badoual, C.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (10) : 2624 - 2629
  • [5] Ellis GL., 2008, TUMORS SALIVARY GLAN, V4, P173
  • [6] Expression of androgen receptor, epidermal growth factor receptor, and transforming growth factor α in salivary duct carcinoma
    Fan, CY
    Melhem, MF
    Hosal, AS
    Grandis, JR
    Barnes, EL
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2001, 127 (09) : 1075 - 1079
  • [7] Goode RK, 2005, World Health Organization Classification of Tumors: Pathology and Genetics of Head and Neck Tumours, P219
  • [8] Ito Fabio Augusto, 2009, Braz. oral res., V23, P393
  • [9] Androgen Receptor-Positive Salivary Duct Carcinoma: A Disease Entity With Promising New Treatment Options
    Jaspers, Heidy C. J.
    Verbist, Berit M.
    Schoffelen, Rafke
    Mattijssen, Vera
    Slootweg, Piet J.
    van der Graaf, Winette T. A.
    van Herpen, Carla M. L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (16) : E473 - E476
  • [10] Systemic therapy in the palliative management of advanced salivary gland cancers
    Laurie, Scott A.
    Licitra, Lisa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (17) : 2673 - 2678